MESOBLAST LTD
MESO · MEOBF · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 20-F ·
Latest disclosures
-
Form 20-F
SEC filing · Filed
-
Obrien James Michael: Form 4
Insider disclosure · Filed · Report period 07 Jul 2026
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Latest financial period: Q2 2025
Financial facts · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0001345099 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- MESO on Nasdaq, MEOBF on OTC
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- Level 38, 55 Collins Street, Melbourne, Victoria, Australia, 3000
- Incorporated in
- Australia
- Fiscal year end
- 30 June
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields